cr.2018-PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
本文檔由 Science 分享于2018-09-04 22:54
暫無(wú)簡(jiǎn)介
手機(jī)或平板掃掃即可繼續(xù)訪問(wèn)
推薦豆丁書(shū)房APP 掃掃更高清